All Pharma News
Agios cashes in on cancer drug again with $905M Royalty Pharma deal

Agios cashes in on cancer drug again with $905M Royalty Pharma deal
Delilah Alvarado BIOPHARMADIVE
28 May 2024
Share Share
Cytokinetics secures up to $575M in royalty deal, frustrating investors

Cytokinetics secures up to $575M in royalty deal, frustrating investors
BIOPHARMADIVE
24 May 2024
Share Share
Cytokinetics, Royalty Pharma Expand Collaboration Up To $575M

Cytokinetics, Royalty Pharma Expand Collaboration Up To $575M
GLOBENEWSWIRE
22 May 2024
Share Share
Royalty Pharma pays startup $525M for stake in Sanofi MS drug

Royalty Pharma pays startup $525M for stake in Sanofi MS drug
Kristin Jensen BIOPHARMADIVE
10 May 2024
Share Share
Royalty Pharma Announces Dividend Increase

Royalty Pharma Announces Dividend Increase
PRESS RELEASE
19 Jan 2024
Share Share
Royalty Pharma Highlights Accomplishments

Royalty Pharma Highlights Accomplishments
PRESS RELEASE
08 Jan 2024
Share Share
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program

Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
BUSINESSWIRE
13 Nov 2023
Share Share
PTC Announces Evrysdi Agreement with Royalty Pharma for Up To $1.5 Billion

PTC Announces Evrysdi Agreement with Royalty Pharma for Up To $1.5 Billion
PR NEWSWIRE
20 Oct 2023
Share Share
Royalty Pharma Declares Fourth Quarter 2023 Dividend

Royalty Pharma Declares Fourth Quarter 2023 Dividend
PRESS RELEASE
16 Oct 2023
Share Share
Royalty Pharma To Announce Third Quarter 2023 Financial Results

Royalty Pharma To Announce Third Quarter 2023 Financial Results
PRESS RELEASE
11 Oct 2023
Share Share